These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8105671)

  • 1. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.
    Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents.
    Kwiterovich PO
    Am J Cardiol; 1993 Sep; 72(10):30D-37D. PubMed ID: 8213494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
    Blaha M; Lanska M; Blaha V; Boudys L; Zak P
    Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia.
    Kolovou GD; Anagnostopoulou KK; Pilatis ND; Giannopoulou M; Hoursalas IS; Pavlidis AN; Adamopoulou E; Valaora AI; Mikhailidis DP; Cokkinos DV
    J Womens Health (Larchmt); 2004 Dec; 13(10):1119-26. PubMed ID: 15650345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.
    Stacpoole PW; Grundy SM; Swift LL; Greene HL; Slonim AE; Burr IM
    J Clin Invest; 1981 Nov; 68(5):1166-71. PubMed ID: 7298845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia: genetic predisposition to atherosclerosis.
    Engler MB
    Medsurg Nurs; 2004 Aug; 13(4):253-7. PubMed ID: 15384479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
    Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
    Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia.
    Holmes DT; Schick BA; Humphries KH; Frohlich J
    Clin Chem; 2005 Nov; 51(11):2067-73. PubMed ID: 16141286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial hypercholesterolemia in children and adolescents: A clinical perspective.
    de Ferranti SD
    J Clin Lipidol; 2015; 9(5 Suppl):S11-9. PubMed ID: 26343208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and case finding in familial hypercholesterolemia.
    Pearson TA
    Am J Cardiol; 1993 Sep; 72(10):15D-17D. PubMed ID: 8213491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress testing response in women heterozygous for familial hypercholesterolemia.
    Kolovou GD; Damaskos DS; Anagnostopoulou KK; Salpea KD; Dritsas A; Giannakopoulou V; Vasiliadis IK; Cokkinos DV
    Int J Cardiol; 2007 Oct; 122(1):96-7. PubMed ID: 17239976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.